: Immune checkpoint inhibitors have significantly improved the therapeutic scenario of many different advanced malignancies and could be an effective treatment strategy in synchronous or metachronous tumors. The authors describe the clinical case of a patient who experienced a long-lasting response of his metastatic renal cell carcinoma and an optimal response of his locally advanced cutaneous squamous cell carcinoma to immunotherapy. The systemic treatment was chosen based on a literature review of several clinical reports, since there was no prospective study on anti-PD-1 blockade activity in cutaneous squamous cell carcinoma when the patient started the treatment. This clinical case supports the growing evidence for immunotherapy as a valid treatment option across different types of advanced tumors.

Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report / Murianni, Veronica; Cerbone, Luigi; Rescigno, Pasquale; Catalano, Fabio; Damassi, Alessandra; Cremante, Malvina; Gandini, Annalice; Puglisi, Silvia; Pesola, Guido; Banna, Giuseppe Luigi; Buti, Sebastiano; Signori, Alessio; Fornarini, Giuseppe; Rebuzzi, Sara Elena. - In: IMMUNOTHERAPY. - ISSN 1750-743X. - 14:18(2022), pp. 1419-1427. [10.2217/imt-2022-0150]

Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report

Buti, Sebastiano;
2022-01-01

Abstract

: Immune checkpoint inhibitors have significantly improved the therapeutic scenario of many different advanced malignancies and could be an effective treatment strategy in synchronous or metachronous tumors. The authors describe the clinical case of a patient who experienced a long-lasting response of his metastatic renal cell carcinoma and an optimal response of his locally advanced cutaneous squamous cell carcinoma to immunotherapy. The systemic treatment was chosen based on a literature review of several clinical reports, since there was no prospective study on anti-PD-1 blockade activity in cutaneous squamous cell carcinoma when the patient started the treatment. This clinical case supports the growing evidence for immunotherapy as a valid treatment option across different types of advanced tumors.
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report / Murianni, Veronica; Cerbone, Luigi; Rescigno, Pasquale; Catalano, Fabio; Damassi, Alessandra; Cremante, Malvina; Gandini, Annalice; Puglisi, Silvia; Pesola, Guido; Banna, Giuseppe Luigi; Buti, Sebastiano; Signori, Alessio; Fornarini, Giuseppe; Rebuzzi, Sara Elena. - In: IMMUNOTHERAPY. - ISSN 1750-743X. - 14:18(2022), pp. 1419-1427. [10.2217/imt-2022-0150]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2936815
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact